Clinical Trial

ZeroOCD: Learn to Overcome Contamination OCD With Your Smartphone

Study acronym: ZeroOCD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is a three-arm randomized controlled trial designed to evaluate the efficacy of a smartphone-based augmented reality (AR) cognitive behavioral therapy (CBT) app, called ZeroOCD, for individuals with elevated contamination-related obsessive-compulsive disorder (OCD) symptoms. The AR-CBT app will be compared to both an active control condition (manualized CBT via videoconferencing) and a waitlist control group.
Trial Details
NCT Number NCT07194473
Lead Sponsor VU University of Amsterdam
Collaborators: University of Bern, Stockholm University, Thomas More University of Applied Sciences
Conditions Obsessive Compulsive Disorder (OCD)
Enrollment 189 participants
Start Date 2025-09-21
Primary Completion 2027-05 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2025-09-26